HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Gdc 0834

HCID 25234918
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
1133432-49-1
Standard SMILES
Cc1c(NC(=O)c2cc3c(s2)CCCC3)cccc1-c1cn(C)c(=O)c(Nc2ccc([C@@H]3C(=O)N(C)CCN3C)cc2)n1
InChIKey
CDOOFZZILLRUQH-GDLZYMKVSA-N
Molecular formula
C33H36N6O3S
Average molar mass
596.7 g/mol
Monoisotopic mass
596.25696021

Names & identifiers

Preferred name
Gdc 0834
IUPAC
N-[3-[6-[4-[(2R)-1,4-dimethyl-3-oxopiperazin-2-yl]anilino]-4-methyl-5-oxopyrazin-2-yl]-2-methylphenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide
English name
GDC0834
Molecular formula
C33H36N6O3S
Molecular weight
596.74

Names & synonyms

GDC-08341133432-49-1FM7JG3L4SRGDC0834GDC 0834Benzo(b)thiophene-2-carboxamide, N-(3-(6-((4-((2R)-1,4-dimethyl-3-oxo-2-piperazinyl)phenyl)amino)-4,5-dihydro-4-methyl-5-oxo-2-pyrazinyl)-2-methylphenyl)-4,5,6,7-tetrahydro-RefChem:142767UNII-FM7JG3L4SRN-[3-[6-[4-[(2R)-1,4-dimethyl-3-oxopiperazin-2-yl]anilino]-4-methyl-5-oxopyrazin-2-yl]-2-methylphenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide(R)-N-(3-(6-((4-(1,4-dimethyl-3-oxopiperazin-2-yl)phenyl)amino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamideCHEMBL2057915DTXSID001025916
Show more names
CS-1263Benzo[b]thiophene-2-carboxamide, N-[3-[6-[[4-[(2R)-1,4-dimethyl-3-oxo-2-piperazinyl]phenyl]amino]-4,5-dihydro-4-methyl-5-oxo-2-pyrazinyl]-2-methylphenyl]-4,5,6,7-tetrahydro-
BDBM503881832VLC33H36N6O3SGDC-0837N-{3-[6-({4-[(2R)-1,4-dimethyl-3-oxopiperazin-2-yl]phenyl}amino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl]-2-methylphenyl }-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamideCPD2GTPL9263orb1709625

Properties

Computed structural propertiesFilling in

XLogP
4.3
Topological polar surface area
126 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
6
Rotatable bonds
6
Heavy atoms
43
Formal charge
0
Complexity
1,140

Physicochemical properties

Density
1.35 · 1.35±0.1 g/cm3(Predicted)
solubility
32 · DMSO:32.0(Max Conc. mg/mL);53.62(Max Conc. mM)
pka
12.46 · 12.46±0.70(Predicted)
form
Solid
color
Light yellow to yellow
FDA UNII
7 JG3L4SR · FM7JG3L4SR
Symbol(GHS)
7 · GHS07
Signal word
Warning
Hazard statements
302 · H302-H315-H319-H335
Precautionary statements
261 · P261-P305+P351+P338

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

Signal word
Warning
Symbol(GHS)
GHS07
Hazard statements
H302-H315-H319-H335
Precautionary statements
P261-P305+P351+P338

Chemistry & industry

Applications

UsesGDC-0834 is a potent and selective BTK inhibitor. GDC-0834 inhibits BTK with an in vitro IC50 of 5.9 and 6.4 nM in biochemical and cellular assays, respectively, and in vivo IC50 of 1.1 and 5.6 μM in mouse and rat, respectively.

Related reactions

1 records
New reaction record
HRID 1363497 reaction equation
HRID 1363497As reactant

Compound notes

On this pageBasic informationNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
1133432-49-1
PubChem CID
25234918
DTXSID
DTXSID001025916
ChEMBL
CHEMBL2057915
UNII
FM7JG3L4SR
Nikkaji
J3.340.008J